News | December 12, 2025
Senores Pharmaceuticals launches of Deferiprone Tablets USP, 500 mg & 1000 mg
The product will be marketed by Dr. Reddy's Laboratories Inc.
The product will be marketed by Dr. Reddy's Laboratories Inc.
The company has unveiled the results of pirtobrutinib from its BRUIN CLL-313 study
The investigational therapy uses SteadyTeq, a proprietary copolymer technology from Medincell designed to release olanzapine steadily over time
The Phase 2 study tested two dose levels of pumitamig alongside four standard chemotherapy regimens across first
Roche says its new assay “resolves this challenge by delivering accurate and specific results
The approval follows strong results from Roche’s phase II NOBILITY and phase III REGENCY studies
The new site marks the company’s first operation in the region
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
The agreement pairs Croda’s global footprint and “smart science” approach with Amino’s precision manufacturing capabilities
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
